Economic Burden of Anti-Methicillin-Resistant Staphylococcus Aureus (Mrsa) Therapy in Public Hospitals of Paris (Ap-Hp) and Adequacy with the Defined Daily Doses
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.451
https://www.valueinhealthjournal.com/article/S1098-3015(16)31818-6/fulltext
Title :
Economic Burden of Anti-Methicillin-Resistant Staphylococcus Aureus (Mrsa) Therapy in Public Hospitals of Paris (Ap-Hp) and Adequacy with the Defined Daily Doses
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31818-6&doi=10.1016/j.jval.2016.09.451
First page :
A424
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
420